Dorian Regulatory Affairs works for a wide range of clients, who have their main business in the Netherlands, the rest of Europe or the United States. Clients include small start-up companies as well as large well-established companies, and any size in-between. The products these companies have in their portfolios are biotechnological or advanced therapy products, as well as conventional products, blood products, or radiopharmaceuticals, and ranging from orphan drugs to potential blockbuster products.
Projects vary from a few days' special assignments to large long-term projects.
For the non-European clients in particular, Dorian Regulatory Affairs can act as your European regulatory affairs department, including being the contact point for the authorities.
As a matter of principle, Dorian Regulatory Affairs does not disclose the identity of her clients to other companies without prior approval. References can be made available on request following approval by those clients.